Apogee Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

APGE

organization

SIC: 2836

SEC Insider

$280.7M

208 transactions

Summary

Apogee Therapeutics, Inc. (APGE) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $95.7MSales: $183.4M15 insiders

Date	Insider	Type	Value
2026-06-22	HENDERSON MICHAEL THOMAS(Chief Executive Officer)	Sell	$10.6M
2026-06-22	Dambkowski Carl(Chief Medical Officer)	Sell	$3.5M
2026-05-13	HENDERSON MICHAEL THOMAS(Chief Executive Officer)	Sell	$1.5M
2026-06-10	HENDERSON MICHAEL THOMAS(Chief Executive Officer)	Sell	$634K
2026-06-10	HENDERSON MICHAEL THOMAS(Chief Executive Officer)	Sell	$557K
2026-06-03	Dambkowski Carl(Chief Medical Officer)	Sell	$433K
2026-06-10	HENDERSON MICHAEL THOMAS(Chief Executive Officer)	Sell	$199K
2026-06-10	HENDERSON MICHAEL THOMAS(Chief Executive Officer)	Sell	$134K
2026-05-13	HENDERSON MICHAEL THOMAS(Chief Executive Officer)	Sell	$111K
2026-06-03	Dambkowski Carl(Chief Medical Officer)	M	$94K
2026-06-10	HENDERSON MICHAEL THOMAS(Chief Executive Officer)	Sell	$91K
2026-06-10	HENDERSON MICHAEL THOMAS(Chief Executive Officer)	Sell	$53K
2026-06-09	Bollinger Lisa	A	$0
2026-06-09	Fox Jennifer A.	A	$0
2026-06-09	JONES WILLIAM A JR	A	$0
2026-06-09	McKenna Mark C.	A	$0
2026-06-09	Shah Nimish P	A	$0
2026-06-09	Joint reporting: Fairmount Funds Management LLC; Kiselak Tomas	A	$0
2026-06-03	Dambkowski Carl(Chief Medical Officer)	M	$0
2026-05-06	Dambkowski Carl(Chief Medical Officer)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Apogee Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope